167 related articles for article (PubMed ID: 15970290)
1. Efficacy of tibolone and transdermal estrogen therapy on psychological symptoms in women following surgical menopause.
Baksu A; Ayas B; Citak S; Kalan A; Baksu B; Goker N
Int J Gynaecol Obstet; 2005 Oct; 91(1):58-62. PubMed ID: 15970290
[TBL] [Abstract][Full Text] [Related]
2. Tibolone improves depression in women through the menopause transition: A double-blind randomized controlled trial of adjunctive tibolone.
Kulkarni J; Gavrilidis E; Thomas N; Hudaib AR; Worsley R; Thew C; Bleeker C; Gurvich C
J Affect Disord; 2018 Aug; 236():88-92. PubMed ID: 29723767
[TBL] [Abstract][Full Text] [Related]
3. [The effects of hormone replacement therapy in menopause on symptoms of anxiety and depression].
Yazici K; Pata O; Yazici A; Aktaş A; Tot S; Kanik A
Turk Psikiyatri Derg; 2003; 14(2):101-5. PubMed ID: 12844276
[TBL] [Abstract][Full Text] [Related]
4. Effects of transdermal estradiol gel and oral tibolone on health-related quality of life after surgical menopause.
Bhattacharya SM; Jha A
Int J Gynaecol Obstet; 2010 Sep; 110(3):213-6. PubMed ID: 20570264
[TBL] [Abstract][Full Text] [Related]
5. Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial.
Baksu B; Baksu A; Göker N; Citak S
Maturitas; 2009 Feb; 62(2):140-5. PubMed ID: 19179026
[TBL] [Abstract][Full Text] [Related]
6. Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause.
Perrone G; Capri O; Galoppi P; Brunelli R; Bevilacqua E; Ceci F; Ciarla MV; Strom R
Gynecol Obstet Invest; 2009; 68(1):33-9. PubMed ID: 19349712
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of tibolone and menopausal transition: a randomized, double-blind placebo-controlled trial.
Morais-Socorro M; Cavalcanti MA; Martins R; Neto Francisco P; Rezende A; Azevedo G; Almeida M
Gynecol Endocrinol; 2012 Jun; 28(6):483-7. PubMed ID: 22132809
[TBL] [Abstract][Full Text] [Related]
8. Effects of tibolone on health-related quality of life in menopausal women.
Bhattacharya SM
Int J Gynaecol Obstet; 2007 Oct; 99(1):43-5. PubMed ID: 17604031
[TBL] [Abstract][Full Text] [Related]
9. A randomized, placebo-controlled, crossover study of tibolone (Livial) on menopause symptoms, psychological well-being, and dyadic relationship of postmenopausal Chinese women and their spouses.
Lam PM; Cheung GW; Shek DT; Lee DT; Haines CJ; Chung TK
Menopause; 2004; 11(4):416-22. PubMed ID: 15243279
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effect of tibolone and transdermal estradiol on triglyceride level in hypertriglyceridemic and normotriglyceridemic postmenopausal women.
Dansuk R; Unal O; Karageyim Y; Esim E; Turan C
Gynecol Endocrinol; 2004 May; 18(5):233-9. PubMed ID: 15346658
[TBL] [Abstract][Full Text] [Related]
11. The effect of tibolone versus 17beta-estradiol on climacteric symptoms in women with surgical menopause: a randomized, cross-over study.
Somunkiran A; Erel CT; Demirci F; Senturk ML
Maturitas; 2007 Jan; 56(1):61-8. PubMed ID: 16831525
[TBL] [Abstract][Full Text] [Related]
12. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.
Nijland EA; Weijmar Schultz WC; Nathorst-Boös J; Helmond FA; Van Lunsen RH; Palacios S; Norman RJ; Mulder RJ; Davis SR;
J Sex Med; 2008 Mar; 5(3):646-56. PubMed ID: 18304284
[TBL] [Abstract][Full Text] [Related]
13. Effects of tibolone on the quality of life, anxiety-depression levels and cognitive functions in natural menopause: an observational follow-up study.
Gülseren L; Kalafat D; Mandaci H; Gülseren S; Camli L
Aust N Z J Obstet Gynaecol; 2005 Feb; 45(1):71-3. PubMed ID: 15730370
[TBL] [Abstract][Full Text] [Related]
14. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG
Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865
[TBL] [Abstract][Full Text] [Related]
15. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
[TBL] [Abstract][Full Text] [Related]
16. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
17. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
[TBL] [Abstract][Full Text] [Related]
18. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group.
Kenemans P; Speroff L;
Maturitas; 2005 May; 51(1):21-8. PubMed ID: 15883105
[TBL] [Abstract][Full Text] [Related]
19. Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.
Sismondi P; Kimmig R; Kubista E; Biglia N; Egberts J; Mulder R; Planellas J; Moggio G; Mol-Arts M; Kenemans P
Maturitas; 2011 Dec; 70(4):365-72. PubMed ID: 22030384
[TBL] [Abstract][Full Text] [Related]
20. [Basic principles of hormone replacement therapy in the postmenopause].
Dören M
Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
